Report Overview:
Internal medicine for pets, also known as veterinary internal medicine, is a specialized field in veterinary science that focuses on diagnosing and treating diseases affecting the internal organ systems of animals. This branch of veterinary medicine covers a wide range of conditions, including metabolic disorders, cardiovascular diseases, gastrointestinal issues, and immune-related conditions. Veterinarians specializing in internal medicine employ advanced diagnostic tools and treatment modalities to ensure the well-being of pets.
Market Value:
The global Pets Internal Medicine market size was estimated at USD 1,648 million in 2023 and is projected to reach USD 2,784.26 million by 2032, growing at a CAGR of 6.00% during the forecast period. CAGR of 6.00% (2025 – 2032)
By Types:
Tablet
Powder
By Applications: Dogs
Cats
Key players include:
• Boehringer Ingelheim
• Zoetis
• Merck
• Elanco
• Bayer
• Virbac
• Ceva Sante Animale
• Including or Excluding key companies relevant to your analysis.
